JULIE LONGMIRE: Open Payments
NPI 1710384193 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,045 in 69 payments from 22 companies in 2025. Trend: 2023 $1,562 · 2024 $1,978 · 2025 $2,045
Food & beverage: $1,960Education: $85
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $444 |
| Novo Nordisk Inc | 11 | $310 |
| INTUITIVE SURGICAL, INC. | 2 | $258 |
| Astellas Pharma US Inc | 4 | $174 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $100 |
| ViiV Healthcare Company | 1 | $98 |
| PFIZER INC. | 6 | $98 |
| Novartis Pharmaceuticals Corporation | 4 | $92 |
| Amgen Inc. | 4 | $67 |
| Aimmune Therapeutics, Inc. | 2 | $65 |
Products named: Da Vinci Surgical System, AIRSUPRA, BREZTRI, Wegovy, CAPLYTA, APRETUDE, LEQVIO, Veozah.
Industry payments across AZ — which companies pay providers there.
